Skip to content
AiSeekAiSeek
Sign in
NewMarketsBusinessFinanceReported 2026-10-09 19:15

City Therapeutics Amends IPO Terms for $175 Million Nasdaq Listing

City Therapeutics has amended its IPO terms to a $17 to $19 range for a $175 million listing on Nasdaq, with Goldman Sachs and Jefferies leading the book.

Why it matters. Investors and analysts will have concrete terms to react to, and the involvement of top underwriters suggests the deal is close to pricing.

01

Who it touches

  1. 1City Therapeutics
  2. ← servesFact
    2Goldman SachsCompany
  3. uses →Fact
    3RNA interferenceTechnology
  4. operates in →Fact
    4RNA interference therapeuticsIndustry
  5. ← servesFact
    5JefferiesCompany
02

Evidence

  • GGDELT Global Knowledge GraphMedia2026-10-09 19:15
    View source